| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | +8.1% | -18.1% |
| Cost of Revenue | $1.5M | +24.9% | +31.4% |
| Gross Profit | $404K | -28.6% | -66.4% |
| R&D Expense | $15.0M | +11.1% | +17.8% |
| SG&A Expense | $5.9M | -14.3% | +2.3% |
| Operating Income | -$20.5M | -3.4% | -18.5% |
| Pre-tax Income | -$201.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.1M | -54.3% | +28.8% |
| Accounts Receivable | $2.3M | +29.9% | -64.3% |
| Current Assets | $456.3M | +5.2% | +339.3% |
| Total Assets | $630.3M | -1.0% | +300.8% |
| Current Liabilities | $11.6M | +11.5% | -45.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$43.6M | — | — |
| Capital Expenditures | $14.1M | — | — |
| Investing Cash Flow | -$389.7M | — | — |
| Financing Cash Flow | $391.9M | — | — |
| Free Cash Flow | -$57.7M | — | — |
| -406.8% |
| -1254.9% |
| Net Income | -$201.0M | -406.8% | -1254.9% |
| EPS (Basic) | -$0.62 | -376.9% | -675.0% |
| EPS (Diluted) | -$0.62 | -376.9% | -675.0% |
| $258.4M |
| +209.8% |
| +651.0% |
| Stockholders' Equity | $371.8M | -32.8% | +202.7% |